These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 37188601

  • 21. Renal transplantation or bladder augmentation first? A comparison of complications and outcomes in children.
    Taghizadeh AK, Desai D, Ledermann SE, Shroff R, Marks SD, Koffman G, Duffy PG, Cuckow PM.
    BJU Int; 2007 Dec; 100(6):1365-70. PubMed ID: 17979933
    [Abstract] [Full Text] [Related]

  • 22. Posterior urethral valves and kidney transplantation: Identifying opportunities for improvement.
    Silverii H, Merguerian P, Fernandez N, Smith J, Shnorhavorian M, Ahn J.
    J Pediatr Urol; 2024 Dec; 20 Suppl 1():S58-S65. PubMed ID: 38969556
    [Abstract] [Full Text] [Related]

  • 23. Renal Transplant in Abnormal Bladder: Treatment Options and Their Effects on Graft Outcome.
    Salman B, Hassan A, Selim M, Abdelbaky T, Sultan S, Halawa A.
    Exp Clin Transplant; 2018 Dec; 16(6):660-664. PubMed ID: 28952922
    [Abstract] [Full Text] [Related]

  • 24. Bladder changes after catheterizable channel creation in adults with cerebral palsy who are in chronic urinary retention.
    Narayan VM, Pariser JJ, Gor RA, Katorski J, Elliott SP.
    Neurourol Urodyn; 2019 Jan; 38(1):165-170. PubMed ID: 30248183
    [Abstract] [Full Text] [Related]

  • 25. Laparoscopic Mitrofanoff procedure in children: critical analysis of difficulties and benefits.
    Blanc T, Muller C, Pons M, Pashootan P, Paye-Jaouen A, El Ghoneimi A.
    J Pediatr Urol; 2015 Feb; 11(1):28.e1-8. PubMed ID: 25697978
    [Abstract] [Full Text] [Related]

  • 26. Renal transplantation into augmented bladders.
    Yamazaki Y, Tanabe K, Ota T, Ito K, Toma H.
    Int J Urol; 1998 Sep; 5(5):423-7. PubMed ID: 9781428
    [Abstract] [Full Text] [Related]

  • 27. Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity.
    Alvares RA, Silva JA, Barboza AL, Monteiro RT.
    Int Braz J Urol; 2010 Sep; 36(6):732-7. PubMed ID: 21176280
    [Abstract] [Full Text] [Related]

  • 28. [Vesicostomy in children. Our experience with 43 patients].
    Queipo Zaragozá JA, Domínguez Hinarejos C, Serrano Durbá A, Estornell Moragues F, Martínez Verduch M, García Ibarra F.
    Actas Urol Esp; 2003 Jan; 27(1):33-8. PubMed ID: 12701496
    [Abstract] [Full Text] [Related]

  • 29. Probability of Bladder Augmentation, Diversion and Clean Intermittent Catheterization in Classic Bladder Exstrophy: A 36-Year, Multi-Institutional, Retrospective Cohort Study.
    Szymanski KM, Fuchs M, Mcleod D, Rosoklija I, Strine AC, VanderBrink B, Whittam B, Yerkes E, Gargollo PC, Pediatric Urology Midwest Alliance (PUMA).
    J Urol; 2019 Dec; 202(6):1256-1262. PubMed ID: 31526259
    [Abstract] [Full Text] [Related]

  • 30. The urological evaluation and management of patients with congenital lower urinary tract anomalies prior to renal transplantation.
    Marshall FF, Smolev JK, Spees EK, Jeffs RD, Burdick JF.
    J Urol; 1982 Jun; 127(6):1078-81. PubMed ID: 7045402
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of electromotive drug administration in delivering botulinum toxin a in children with neuropathic detrusor overactivity-outcomes of a pilot study.
    Koh C, Melling CV, Jennings C, Lewis M, Goyal A.
    J Pediatr Urol; 2019 Oct; 15(5):552.e1-552.e8. PubMed ID: 31326328
    [Abstract] [Full Text] [Related]

  • 32. Clinical outcomes of non-surgical management of detrusor leak point pressures above 40 cm water in adults with congenital neurogenic bladder.
    Lane GI, Gor RA, Katorski J, Elliott SP.
    Neurourol Urodyn; 2018 Aug; 37(6):1943-1949. PubMed ID: 29488655
    [Abstract] [Full Text] [Related]

  • 33. Is cystoplasty a safe alternative to urinary diversion in patients requiring renal transplantation?
    McInerney PD, Picramenos D, Koffman CG, Mundy AR.
    Eur Urol; 1995 Aug; 27(2):117-20. PubMed ID: 7744152
    [Abstract] [Full Text] [Related]

  • 34. Urodynamic Outcomes in Children after Single and Multiple Injections for Overactive and Low Compliance Neurogenic Bladder Treated with Abobotulinum Toxin A.
    Naqvi S, Clothier J, Wright A, Garriboli M.
    J Urol; 2020 Feb; 203(2):413-419. PubMed ID: 31518199
    [Abstract] [Full Text] [Related]

  • 35. Comparative urodynamic findings after primary valve ablation, vesicostomy or proximal diversion.
    Kim YH, Horowitz M, Combs A, Nitti VW, Libretti D, Glassberg KI.
    J Urol; 1996 Aug; 156(2 Pt 2):673-6. PubMed ID: 8683757
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cutaneous vesicostomy revisited--the second 15 years.
    Vastyan AM, Pinter AB, Farkas A, Vajda P, Somogyi R, Juhasz Z.
    Eur J Pediatr Surg; 2005 Jun; 15(3):170-4. PubMed ID: 15999309
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.